C-erbB-2 onco-protein expression in breast cancer: relationship to tumour characteristics and short-term survival in Universiti Kebansaan Malaysia Medical Centre.

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Regression Models and Life-Tables

1992 • 27,454 citations

Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene

1987 • 11,429 citations

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

2001 • 11,070 citations

Evaluation of survival data and two new rank order statistics arising in its consideration.

1966 • 7,595 citations

Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease

1999 • 2,747 citations

USE OF CHEMOTHERAPY PLUS A MONOCLONAL ANTIBODY AGAINST HER2 FOR METASTATIC BREAST CANCER THAT OVEREXPRESSES HER2

2009 • 1,262 citations

Assessment of Methods for Tissue-Based Detection of the HER-2/neu Alteration in Human Breast Cancer: A Direct Comparison of Fluorescence In Situ Hybridization and Immunohistochemistry

2000 • 690 citations

The HER-2/neu Gene and Protein in Breast Cancer 2003: Biomarker and Target of Therapy

2003 • 604 citations

Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.

1988 • 570 citations

Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research

1995 • 374 citations

Significance of Axillary Lymph Node Metastasis in Primary Breast Cancer

1999 • 292 citations

Follow-up study of HER-2/neu amplification in primary breast cancer.

1991 • 268 citations

Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study.

2003 • 209 citations

HER2 Testing in Patients With Breast Cancer: Poor Correlation Between Weak Positivity by Immunohistochemistry and Gene Amplification by Fluorescence In Situ Hybridization

2002 • 193 citations

Epidemiology of breast cancer in Malaysia.

2006 • 173 citations

correlation between histologic grade of malignancy and copy number of c-erbb-2 gene in breast carcinoma. A retrospective analysis of 176 cases

1990 • 152 citations

Optimization of immunohistochemical detection of ERBB2 in human breast cancer: Impact of fixation

1994 • 123 citations

Spectrum of Breast Cancer in Malaysian Women: Overview

2003 • 120 citations

Predicting the HER2 status of breast cancer from basic histopathology data: an analysis of 1500 breast cancers as part of the HER2000 International Study

2003 • 106 citations

Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma.

1990 • 95 citations

Predictive and prognostic markers for invasive breast cancer

2002 • 56 citations

Immunohistochemical Determination of Estrogen and Progesterone Receptor Status in Breast Cancer

1993 • 44 citations

Cancer incidence in Malaysia.

1979 • 25 citations

Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.

2002 • 23 citations

C-erbB-2 oncoprotein amplification in infiltrating ductal carcinoma of breast relates to high histological grade and loss of oestrogen receptor protein.

1998 • 18 citations

Short-Term Survival in Breast Cancer: The Experience of the University of Malaya Medical Centre

2003 • 8 citations

Correlation between histological grade and c-erbB2 oncoprotein overexpression in infiltrating ductal carcinoma of breast.

1997 • 2 citations